Cooley advised Iterum Therapeutics plc on its $80 million initial public offering of 6,150,000 ordinary shares. The underwriters have a 30-day option to purchase up to…
Iterum Therapeutics’ $80 Million Initial Public Offering
Cooley advised Iterum Therapeutics plc on its $80 million initial public offering of 6,150,000 ordinary shares. The underwriters have a 30-day option to purchase up to…